In just a couple of days, the oncology
community of physicians, scientists and researchers,
allied medical professionals, advocates, the
pharmaceutical and biotechnology industry, and others,
will gather in Chicago, for the 49th Annual Meeting of
the American Society of Clinical Oncology (ASCO).
This annual meeting will bring together 30,000 cancer
specialists from around the world, presenting
educational sessions, posters, and as many as 5000
abstracts, sharing data and the results of clinical
trials and research on a global scale.  It is at
such meetings where shared discoveries will often lead
to new standards and practice-changing patient care,
innovation, and hope.

The Group Room and other Vital
Options programs are now in a video format, but we
continue reporting on the latest scientific findings,
clinical advances, human interest stories, and the
progress being made by cancer advocates throughout the
country.
 

Until soon
then.

Best of
wishes,

Vital Options
International presents Advocacy In Action,
bringing together cancer advocacy leadership to
address:

Genomics Of
Metastatic Cancer

Palliative
Care

Lung
Cancer Treatment Guidelines & Molecular
Testing   

Sunday,
June 2 | 11:00am – 1:30pm

Hyatt
McCormick Place

Room
CLARK AB

11:00-11:30:
Meet & Greet Reception with
Snacks

11:30-11:50:
Genomics of Metastatic Cancer

11:55-12:50:
Palliative Care

12:55-1:30:
Lung Cancer Treatment Guidelines & Molecular
Testing

Heinz-Josef
Lenz, MD, FACP, Associate Director for Clinical
Research and Co-Leader of the GI Oncology Program, USC
Norris Comprehensive Cancer Center

Shirley
Mertz, President, Metastatic Breast Cancer
Network

Palliative
Care 

Jamie
H. Von Roenn, MD – Professor of Medicine,
Division of Hematology/Oncology; Feinberg School of
Medicine, Northwestern University; Robert H. Lurie
Comprehensive Cancer Center;   Chair, ASCO thematic
meeting—Palliative Care in Oncology; Chair of the ASCO
Leadership Development Program, Chair of the ASCO
Professional Development Committee; Co-Chair of the
AACR-ASCO Clinical Trials Workshop, and Chair of the
2014, ASCO thematic meeting—Palliative Care in
Oncology

Linda
House, RN, BSN, MSM – Executive Vice President
of External Affairs, Cancer Support Community, and
C-Change (for which she Co-Chairs the Guidance
Subcommittee of the C-Change Assuring Value in Cancer
Care Advisory Committee)

Helen
Miller, LCSW – CEO, CancerCare

Shirley
Mertz, President, Metastatic Breast Cancer
Network

Lung
Cancer Treatment Guidelines & Molecular
Testing

David
R. Spigel, MD – Director, Lung Cancer Research
Program at Sarah Cannon Research Institute and a Medical
Oncologist at Tennessee Oncology, PLLC, Nashville,
TN

Ming
S. Tsao, MD, FRCPC – Princess Margaret Cancer
Centre, Toronto, Canada

Andrea
Stern Ferris – President, LUNGevity

Kim
Norris – Founder/President, Lung Cancer
Foundation of America

Regina
Vidaver, PhD – Executive Director, National
Lung Cancer Partnership

 

   

In just a couple of days, the oncology
community of physicians, scientists and researchers,
allied medical professionals, advocates, the
pharmaceutical and biotechnology industry, and others,
will gather in Chicago, for the 49th Annual Meeting of
the American Society of Clinical Oncology (ASCO).
This annual meeting will bring together 30,000 cancer
specialists from around the world, presenting
educational sessions, posters, and as many as 5000
abstracts, sharing data and the results of clinical
trials and research on a global scale.  It is at
such meetings where shared discoveries will often lead
to new standards and practice-changing patient care,
innovation, and hope.

The Group Room and other Vital
Options programs are now in a video format, but we
continue reporting on the latest scientific findings,
clinical advances, human interest stories, and the
progress being made by cancer advocates throughout the
country.
 

Until soon
then.

Best of
wishes,

Vital Options
International presents Advocacy In Action,
bringing together cancer advocacy leadership to
address:

Genomics Of
Metastatic Cancer

Palliative
Care

Lung
Cancer Treatment Guidelines & Molecular
Testing   

Sunday,
June 2 | 11:00am – 1:30pm

Hyatt
McCormick Place

Room
CLARK AB

11:00-11:30:
Meet & Greet Reception with
Snacks

11:30-11:50:
Genomics of Metastatic Cancer

11:55-12:50:
Palliative Care

12:55-1:30:
Lung Cancer Treatment Guidelines & Molecular
Testing

Heinz-Josef
Lenz, MD, FACP, Associate Director for Clinical
Research and Co-Leader of the GI Oncology Program, USC
Norris Comprehensive Cancer Center

Shirley
Mertz, President, Metastatic Breast Cancer
Network

Palliative
Care 

Jamie
H. Von Roenn, MD – Professor of Medicine,
Division of Hematology/Oncology; Feinberg School of
Medicine, Northwestern University; Robert H. Lurie
Comprehensive Cancer Center;   Chair, ASCO thematic
meeting—Palliative Care in Oncology; Chair of the ASCO
Leadership Development Program, Chair of the ASCO
Professional Development Committee; Co-Chair of the
AACR-ASCO Clinical Trials Workshop, and Chair of the
2014, ASCO thematic meeting—Palliative Care in
Oncology

Linda
House, RN, BSN, MSM – Executive Vice President
of External Affairs, Cancer Support Community, and
C-Change (for which she Co-Chairs the Guidance
Subcommittee of the C-Change Assuring Value in Cancer
Care Advisory Committee)

Helen
Miller, LCSW – CEO, CancerCare

Shirley
Mertz, President, Metastatic Breast Cancer
Network

Lung
Cancer Treatment Guidelines & Molecular
Testing

David
R. Spigel, MD – Director, Lung Cancer Research
Program at Sarah Cannon Research Institute and a Medical
Oncologist at Tennessee Oncology, PLLC, Nashville,
TN

Ming
S. Tsao, MD, FRCPC – Princess Margaret Cancer
Centre, Toronto, Canada

Andrea
Stern Ferris – President, LUNGevity

Kim
Norris – Founder/President, Lung Cancer
Foundation of America

Regina
Vidaver, PhD – Executive Director, National
Lung Cancer Partnership